Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 424B5 Offering Prospectus
  2. 8-K Event Other events
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-3/A Offering Registration Statement
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. S-1/A Offering Registration Statement
  10. UPLOAD Other SEC-generated Letter
  11. S-1 Offering Registration Statement
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. 4 Insider Changes in Ownership
  15. 4/A Insider Changes in Ownership
  16. 8-K Event Executive or director change
  17. 3 Insider Initial Statement of Ownership
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. S-3/A Offering Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 28 of 89 · 1,773 filings